Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Cuchural GJ Jr, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C.

Antimicrob Agents Chemother. 1990 Mar;34(3):479-80.

2.

Newer beta-lactam agents and the Bacteroides fragilis group.

Cuchural GJ Jr.

Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Review.

PMID:
2041832
3.

Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.

O'Keefe JP, Venezio FR, DiVincenzo CA, Shatzer KL.

Antimicrob Agents Chemother. 1987 Dec;31(12):2002-4.

4.

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

Cornick NA, Cuchural GJ Jr, Snydman DR, Jacobus NV, Iannini P, Hill G, Cleary T, O'Keefe JP, Pierson C, Finegold SM.

J Antimicrob Chemother. 1990 Jun;25(6):1011-9.

PMID:
2370237
5.
6.

Survey of Bacteroides fragilis group susceptibility patterns in Canada.

Bourgault AM, Lamothe F, Hoban DJ, Dalton MT, Kibsey PC, Harding G, Smith JA, Low DE, Gilbert H.

Antimicrob Agents Chemother. 1992 Feb;36(2):343-7.

8.

Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

Cuchural GJ Jr, Snydman DR, McDermott L, Iannini PB, Hill GB, Cleary TJ, O'Keefe JP, Pierson CL, Rihs JD, Finegold SM.

Clin Ther. 1992 Jan-Feb;14(1):122-36.

PMID:
1576621
9.
10.

Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.

Jacobus NV, Tally FP, Gorbach SL.

J Antimicrob Chemother. 1985 Jun;15 Suppl C:189-91.

PMID:
4030547
11.

In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.

Betriu C, Sánchez A, Gómez M, Palau ML, Picazo JJ.

J Antimicrob Chemother. 1999 Jan;43(1):133-6.

PMID:
10381111
13.
15.

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Cuchural GJ Jr, Tally FP, Jacobus NV, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C, et al.

Antimicrob Agents Chemother. 1988 May;32(5):717-22.

16.

In vitro susceptibility of the Bacteroides fragilis group in community hospitals.

File TM Jr, Thomson RB Jr, Tan JS, Salstrom SJ, Jacobs GA, Johnson L, Tan L.

Diagn Microbiol Infect Dis. 1986 Nov;5(4):317-22.

PMID:
3465493
17.

Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.

Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G.

J Hyg Epidemiol Microbiol Immunol. 1991;35(2):189-97.

PMID:
1940333
19.

Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.

Horn R, Lavallée J, Robson HG.

Antimicrob Agents Chemother. 1992 Sep;36(9):2051-3.

20.

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Betriu C, Campos E, Cabronero C, Rodriguez-Avial C, Picazo JJ.

Antimicrob Agents Chemother. 1990 Apr;34(4):671-3.

Supplemental Content

Support Center